Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H12O7 |
Molecular Weight | 316.2623 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O)C=CC(=C1)C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2
InChI
InChIKey=IZQSVPBOUDKVDZ-UHFFFAOYSA-N
InChI=1S/C16H12O7/c1-22-11-4-7(2-3-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3
Molecular Formula | C16H12O7 |
Molecular Weight | 316.2623 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Isorhamnetin, a flavonol aglycone, isolated from the traditional Chinese medicine H. rhamnoides L., was frequently used in traditional medicine to prevent and treat diverse diseases. Isorhamnetin has been shown to play a variety of roles in anti-oxidation, anti-inflammation, anti-tumor, anti-viral, and neurodegenerative injury protection. Isorhamnetin could inhibit the H2O2-induced activation of the intrinsic apoptotic pathway by scavenging free ROS and extracellular signal-regulated kinase 1/2 (ERK1/2) inactivation. In the type 2 diabetic rat model, isorhamnetin was found to be able to inhibit the NF-κB signaling activity, attenuate oxidative stress, and decrease the production of inflammatory mediators. Isorhamnetin can suppress skin cancer, breast cancer, colon cancer and atherosclerosis by inhibiting PI3K/AKT activation. Isorhamnetin shows inhibitory activity toward CYP1B1 expression and function.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2231 |
56.0 nM [IC50] | ||
Target ID: CHEMBL3356 |
1.3 µM [IC50] | ||
Target ID: CHEMBL4878 |
17.0 nM [IC50] | ||
Target ID: map04151 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28176246 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
The role of transthyretin in the transport of thyroid hormone to cerebrospinal fluid and brain. | 1992 |
|
[The effects of quercetin and isorhamnetin on oxidative modification of VLDL induced by Cu2+]. | 2001 Jun |
|
Polyphenolic compounds from the leaves of Koelreuteria paniculata Laxm. | 2002 Dec |
|
[Studies on chemical constituents of Cuscuta chinensis]. | 2002 Feb |
|
EGb 761: ginkgo biloba extract, Ginkor. | 2003 |
|
Chemical characterization and biological effects of Sicilian Opuntia ficus indica (L.) mill. Fruit juice: antioxidant and antiulcerogenic activity. | 2003 Aug 13 |
|
[Ginkgo flavones in in vitro metabolism and its clinical application]. | 2003 Dec |
|
Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats. | 2003 Dec |
|
Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations. | 2003 Jan 31 |
|
Structure-antioxidant efficiency relationships of phenolic compounds and their contribution to the antioxidant activity of sea buckthorn juice. | 2003 Jul 16 |
|
Flavonol and drimane-type sesquiterpene glycosides of Warburgia stuhlmannii leaves. | 2003 Jun |
|
Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. | 2003 Jun 15 |
|
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity. | 2003 May |
|
Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. | 2003 May 15 |
|
Effects of the flavonoid quercetin and its methylated metabolite isorhamnetin in isolated arteries from spontaneously hypertensive rats. | 2003 Nov |
|
Phenols and flavonoids in Aleppo pine needles as bioindicators of air pollution. | 2003 Nov-Dec |
|
Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. | 2003 Oct |
|
Flavonoid intake and breast cancer risk: a case--control study in Greece. | 2003 Oct 6 |
|
Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102. | 2003 Sep 9 |
|
Bioactive phenolics from Carthamus lanatus L. | 2003 Sep-Oct |
|
Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. | 2004 Dec |
|
Cytoprotection by neutral fraction of tannat red wine against oxidative stress-induced cell death. | 2004 Dec 1 |
|
Protective effects of quercetin and its metabolites on H2O2-induced chromosomal damage to WIL2-NS cells. | 2004 Feb |
|
Chemical taxonomy of the Xibei tree peony from China by floral pigmentation. | 2004 Feb |
|
[Studies on the flavonoid compounds of Rhododendron anthopogonoides]. | 2004 Jan |
|
Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols. | 2004 Jan |
|
[Glucuronidation and in vitro interaction of Ginkgo flavonoids with other drugs]. | 2004 Jan |
|
Isotamarixen - a new antioxidant and prolyl endopeptidase-inhibiting triterpenoid from Tamarix hispida. | 2004 Jan |
|
Estrogenic activities of Ginkgo biloba extracts. | 2004 Jan 30 |
|
Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. | 2004 Jul 14 |
|
Structural requirements of flavonoids for increment of ocular blood flow in the rabbit and retinal function recovery in rat eyes. | 2004 Jun |
|
Phytochemical analysis of ethyl acetate extract from Astragalus corniculatus Bieb. and brain antihypoxic activity. | 2004 Jun |
|
Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. | 2004 Jun |
|
The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. | 2004 Jun |
|
Structural investigations of flavonol glycosides from sea buckthorn (Hippophaë rhamnoides) pomace by NMR spectroscopy and HPLC-ESI-MS(n). | 2004 Jun 30 |
|
Urinary excretion of flavonoids reflects even small changes in the dietary intake of fruits and vegetables. | 2004 May |
|
The protozoan Tetrahymena as a bioindicator to screen bioactive substances. | 2004 Nov |
|
Characterisation of flavonols in broccoli (Brassica oleracea L. var. italica) by liquid chromatography-uV diode-array detection-electrospray ionisation mass spectrometry. | 2004 Oct 29 |
|
Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity. | 2004 Sep 13 |
|
High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms. | 2004 Sep 24 |
|
Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. | 2005 |
|
Antiinflammatory constituents from the roots of Smilax bockii warb. | 2005 Apr |
|
The simultaneous determination of selected flavonol glycosides and aglycones in Ginkgo biloba oral dosage forms by high-performance liquid chromatography-electrospray ionisation-mass spectrometry. | 2005 Apr 1 |
|
Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. | 2005 Feb 18 |
|
[Applications of two-dimensional liquid chromatography coupled to mass spectrometry for the separation and identification of compounds in ginkgo biloba extracts]. | 2005 Jan |
|
The influence of Calendulae officinalis flos extracts on cell cultures, and the chromatographic analysis of extracts. | 2005 Jun 15 |
|
Quercetin metabolism in vital and apoptotic human leukaemia cells. | 2005 Mar |
|
Total flavones of Hippophae rhamnoides promotes early restoration of ultimate stress of healing patellar tendon in a rat model. | 2005 May |
|
Isolation of five types of flavonol from seabuckthorn (Hippophae rhamnoides) and induction of apoptosis by some of the flavonols in human promyelotic leukemia HL-60 cells. | 2005 May |
|
Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human breast cancer cells, by high-performance liquid chromatography. | 2005 Sep 1 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28176246
Mice: 100 mg/kg/day for 8 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28962277
Isorhamnetin (3-O-methyl quercetin) had no effect on human neuroblastoma SH-SY5Y cells viability even at 100 uM and even in presence of 500 uM ascorbic acid
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 20:05:49 GMT 2023
by
admin
on
Sat Dec 16 20:05:49 GMT 2023
|
Record UNII |
07X3IB4R4Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5281654
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
1351800
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
207-545-5
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
ISORHAMNETIN
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
6052
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
144055
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
07X3IB4R4Z
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
DTXSID10197379
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY | |||
|
480-19-3
Created by
admin on Sat Dec 16 20:05:49 GMT 2023 , Edited by admin on Sat Dec 16 20:05:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |